CRP and lymphopenia: Research has demonstrated that, compared to COVID-19 patients without diabetes, those with diabetes exhibit a higher incidence of lymphopenia (44.5% vs. 32.6%) and elevated levels of inflammatory markers (C-reactive protein: 57.0% vs. 42.4%, procalcitonin: 33.3% vs. 20.3%) (18).